Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Gonzalez, J. (J.) | - |
dc.creator | Pardo, F. (Fernando) | - |
dc.creator | Álvarez-Cienfuegos, J. (Javier) | - |
dc.creator | Hernandez-Lizoain, J.L. (Jose Luis) | - |
dc.creator | Villa, V. (V.) de | - |
dc.creator | Torramade, J. (J.) | - |
dc.creator | Diaz, M.C. (M. C.) | - |
dc.creator | Pardo-Mindan, F.J. (Francisco Javier) | - |
dc.creator | Ortigosa, C.R. (C.R.) | - |
dc.date.accessioned | 2014-09-29T11:46:25Z | - |
dc.date.available | 2014-09-29T11:46:25Z | - |
dc.date.issued | 1992 | - |
dc.identifier.citation | González J, Pardo F, Cienfuegos JA, Hernández JL, de Villa V, Torramadé J, et al. Plasma levels of leukotriene B4 during hepatic allograft rejection. Transplant Proc. 1992 Feb;24(1):143-4. | es_ES |
dc.identifier.issn | 0041-1345 | - |
dc.identifier.uri | https://hdl.handle.net/10171/36771 | - |
dc.description.abstract | At the present time, rejection is the most frequent cause of graft dysfunction in liver transplantation. Differential diagnosis between this and other possible causes of dysfunction—preservation injury, vascular, biliary, viral—may well be difficult, as the clinical and analytical findings are often similar; moreover, no markers specific to rejection are available, and histological studies are necessary for a definitive diagnosis. For this reason, markers indicating activity within the immune system need to be established so as to provide a more specific means of distinguishing rejection from other causes of graft dysfunction. The immune response to an allograft is complex, and the intricate mechanisms regulating it are still not entirely understood. Nevertheless, several specialists have drawn connections among changes in the lymphocyte subpopulations, rises in the interleukin-2 levels, expression of the interleukin-2 receptor, and alteration in the expression of antigens belonging to class II in the greater complex of histocompatibility, with rejection of the allograft. Leukotriene B4 (LTB4) is a derivative of the metabolism of arachidonic acid via 5- lipoxygenase, whose in vitro behaviour is to encourage rejection by favoring leukocyte aggregation, proliferation of T lymphocytes, interleukin-1 and -2 secretion, and the development of "natural killer" cell subpopulations. This study examines the role of LTB4 in mediating the immune response to the hepatic allograft in order to assess its usefulness in early diagnosis of rejection. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Liver Transplantation/physiology | es_ES |
dc.subject | Leukotriene B4/blood | es_ES |
dc.subject | Biological Markers/blood | es_ES |
dc.subject | Graft Rejection | es_ES |
dc.title | Plasma levels of leukotriene B4 during hepatic allograft rejection | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.